Introduction
How multicellular organisms orchestrate the growth of their individual cells and organs is a fundamental question that has fascinated generations of biologists. In recent years, a great deal has been learned about tissue growth control, but it is clear that our understanding of this process is far from complete. The identification of a novel signalling network -the Salvador-Warts-Hippo (SWH) pathwayas a crucial determinant of organ size has provided a new entry point into the question of organ-size control [1] . The SWH pathway was first discovered in Drosophila melanogaster and was subsequently shown to play a similar growth-regulatory role in mice [1] [2] [3] . In addition, deregulation of SWH pathway activity has been implicated in the formation of different types of human cancer [4, 5] . This suggests that the growth-regulatory activity of the SWH pathway is conserved in humans, and that therapeutic modulation of SWH pathway activity represents a viable option to modulate aberrant tissue growth in human hypertrophic diseases or in cancer.
The SWH pathway limits tissue growth by restricting cell growth and proliferation and by promoting apoptosis.
A growing number of proteins have been implicated as components of this pathway and can be broadly classified into core, downstream and upstream members (Figure 1 ). Proteins that constitute the core kinase module of the SWH pathway were identified in Drosophila genetic screens on the basis that their loss led to egregious tissue growth. These proteins are the Ser/Thr kinases Warts (Wts) and Hippo (Hpo), and the adaptor proteins Salvador (Sav) and Mob as tumour suppressor (Mats) [1, [6] [7] [8] [9] [10] [11] [12] . Core SWH pathway proteins repress tissue growth largely by phosphorylating, and thereby inhibiting, the growth-promoting transcriptional co-activator Yorkie (Yki) [13] . Yki promotes growth by modulating the activity of transcription factors, and together these proteins can be classified as downstream SWH pathway members. In recent years, an increasingly complex picture has emerged with regards to the growth-regulatory role of both downstream and upstream SWH pathway proteins. At least three transcription factors -Scalloped [14] [15] [16] , Homothorax and Teashirt [17] -have been reported to mediate the growth-regulatory function of Yki, whilst further transcriptional regulatory proteins are likely to exist [18, 19] .
Several reviews have distilled our current knowledge of core SWH pathway proteins [4, 5, 20, 21] . The focus of this review is to highlight a spate of recent reports that has described a growing number of proteins that regulate the core SWH pathway kinase cassette and Yki. Such proteins can be broadly termed upstream SWH pathway proteins. The majority of these proteins can be grouped into three major categories: proteins that signal via the atypical cadherin, Fat, which functions as a transmembrane receptor for the SWH pathway; the Kibra-Expanded-Merlin complex, which has recently been shown to provide a direct link from the apical membrane to core SWH pathway proteins; and the apicobasal polarity proteins ( Figure 1 ). Upstream regulators are clustered on the basis of their mutant phenotypes ( Figure 2 ) and by their physical interactions (Table 1) , but proteins from each branch display evidence of interfacing with members of other branches (Figures 1 and 3) . As described below, an increasingly complex picture is emerging of the mechanism by which upstream regulatory proteins 'fine-tune' growth regulation by the SWH pathway.
Fat Signalling outside the Cell -Fat, Dachsous and Four-jointed Fat (Ft) and Dachsous (Ds) are atypical cadherins that control organ growth, planar cell polarity and proximal-distal patterning [22] [23] [24] [25] [26] [27] . Mutation of ft and, to a lesser degree, mutation of ds results in tissue overgrowth [22, 28] . In 2006, work by several groups revealed that Ft controls growth upstream of the SWH pathway [29] [30] [31] . With this discovery, a transmembrane receptor for the SWH pathway had been revealed that could potentially relay extracellular signals through to the core components of the pathway.
More recently Ds was shown to control growth via the SWH pathway by functioning as a ligand for Ft [32, 33] , a finding that extended the functional link between these proteins, which had previously been shown to interact [34] , influence each other's localisation [35] , and co-ordinately Interactions between different components of the SWH pathway are shown (positive interactions are signified by arrows, whereas inhibitory interactions are indicated by blocked lines). Lethal giant larvae (Lgl) and atypical protein kinase C (aPKC) affect localisation of Hippo (Hpo) and Drosophila Ras association family protein (dRASSF) but the functional consequence is unclear. Proteins in green activate Yorkie (Yki), while proteins in red inhibit Yki. The SWH pathway controls tissue growth by regulating the subcellular localisation of Yki, which, when nuclear, associates with cognate transcription factors (TFs), and activates a transcriptional program that drives cell growth and proliferation, and inhibits apoptosis. Several upstream inputs regulate the activity of the core SWH components Salvador (Sav), Hpo, Warts (Wts) and Mob as tumour suppressor (Mats). Fat (Ft)-dependent signalling is displayed on the left side of the cell. Ft signals to the core components by controlling the localisation of Dachs (D) and by influencing the localisation and levels of Expanded (Ex). Ft activity is controlled by its ligand Dachsous (Ds), by the kinases Four-jointed (Fj) and Discs overgrown (Dco), and by Lowfat (Lft), Approximated (App) and Dachs (D). Kibra, Ex and Merlin (Mer) form a complex that is depicted on the right side of the cell, along with dRASSF and the apicobasal polarity proteins, Crumbs (Crb), aPKC and Lgl. For a complete overview of protein-protein interactions between pathway members refer to Table 1. regulate planar cell polarity (reviewed in [36, 37] ). Interestingly, activation of the Ft receptor by Ds does not occur in a classical ligand-concentration-dependent manner. Instead, it appears that relative levels of Ft and Ds between cells control the activity of Ft [32, 33] . For example, when cells expressing high levels of Ds are placed next to cells expressing low levels of Ds, activation of SWH pathway target genes ensues on both sides of the boundary between high and normal Ds expression [32, 33] . This clonal boundary effect is seen several cell diameters away from the clone, suggesting that the signal can be propagated from one cell to its neighbours, possibly via cell-surface interactions between Ft and Ds. The binding of Ft and Ds is modulated by the kinase Four-jointed (Fj). Fj phosphorylates Ft and Ds on their extracellular domains as they are trafficked through the Golgi apparatus and thereby modifies the Ft-Ds interaction [38] . Interestingly, Fj appears to have a dual role in modulating Ft-Ds binding. By phosphorylating Ds, it reduces the ability of Ds to bind to Ft [39, 40] , whereas by phosphorylating Ft it increases Ft's ability to bind to Ds [40] . The opposing roles of Fj on Ft and Ds could thus cause polarisation of Ft activity within cells, and this is thought to be required for Ft's function in size control (for a model, refer to [40] ). Ds and Fj are expressed in complementary gradients in many tissues of Drosophila [34, 41] , and their expression levels are controlled by morphogens such as Wingless (Wg) and Decapentaplegic (Dpp) [26, 33] . The discoveries that morphogens regulate the graded expression of Ds and Fj, and that Ds and Fj in turn control Ft activity, leading to tissue-growth regulation through the SWH pathway, provide an attractive model for how organ growth is controlled by the SWH pathway downstream of morphogens [42] .
Interestingly, there is evidence that Ds functions not only as a ligand but also as a receptor [32, 43] . Ds-overexpressing clones in ds mutant discs result in the upregulation of SWH pathway target genes only at the clonal border on the inside of the clone, where Ds is present. Unlike the situation in the wild-type disc, no clonal boundary effect is seen on the outside of the clone [32] . Furthermore, ft, ds double mutant discs are more overgrown than ft or ds single mutant discs [28] . Whether Ds signals cell-autonomously via the SWH pathway to control tissue growth, and whether this signal is also relayed through the intracellular transducer of Ft signalling, termed Dachs (D), remains to be established. The tissue overgrowth of ds mutants is a lot weaker than that of ft mutants, suggesting either that Ft can signal in a partially ligand-independent fashion or that other growth-regulatory Ft ligands also exist.
Two potential mechanisms have been described by which Ft can regulate SWH pathway activity (Figure 1 ): Ft influences Wts protein stability, as revealed by the finding that Wts levels are greatly reduced in ft mutant tissue [44] ; or Ft regulates the levels and subcellular localisation of Ex, given that Ex protein levels are reduced and/or shifted to a more subapical region in ft-deficient tissue [29] [30] [31] . Both of these phenotypes depend on D (see below) [44, 45] . Research from the McNeill and Irvine laboratories added a new twist to Ft signalling: they found that Ft protein is proteolytically cleaved at the base of its extracellular domain, and that the resultant cleavage products formed heterodimers [46, 47] . This phenomenon is reminiscent of cleavage of the Notch receptor protein, although the biological significance of Ft cleavage and the mechanism by which it is regulated are currently unclear.
Fat Signalling inside the Cell -Discs overgrown and Lowfat
Ft is not only phosphorylated at its extracellular domain by Fj, but also at its intracellular domain (ICD) by the casein kinase Discs overgrown (Dco) [46, 47] . The phosphorylated form of Ft-ICD seems to be active in growth suppression because mutation of either dco or the Ft ligand ds corresponds with reduced Ft-ICD phosphorylation and stimulation of Yki-dependent tissue overgrowth. Although phosphorylation of Ft-ICD is reduced in tissue homozygous for the dco 3 mutation, it is not abolished, suggesting the presence of other Ft-ICD regulatory kinases [46, 47] . How is phosphorylation of Ft-ICD regulated? It has been previously shown that Ft and Ds recruit each other to membrane [34] . Taken together with the observations that Ds promotes phosphorylation of Ft [46, 47] and that the Ft-ICD can form dimers when overexpressed in HEK293 T cells [47] , Sopko and colleagues suggested that Ds promotes clustering of the Ft receptor, and that this clustering might be required for efficient Ft phosphorylation [47] . Dco phosphorylates Ft-ICD at multiple residues, but at present the specific phosphorylation sites and their biological significance have not been identified. Analysis of Ft's phosphorylation sites should shed further light on how Ft signals to downstream effectors to control planar cell polarity and SWH pathway signalling. Another open question regarding Ft-Ds signalling relates to the regulation of Ds. The ICD of Ds, which is similar to that of Ft, was found to be phosphorylated in both Drosophila embryos and cultured cells [48, 49] , but the biological function of this phosphorylation, and its relevance to Ft signalling have not been explored.
Ft and Ds activity are not only regulated by phosphorylation, but also through regulation of their protein stabilities. This regulation is mediated by the cytoplasmic protein Lowfat (Lft). Lft has no known domains [50] and was identified as a regulator of Ft and Ds by virtue of its interaction with these proteins in a genome-wide yeast two-hybrid screen [51] . Lft regulates the protein stability of Ft and Ds; loss of Lft strongly reduces Ft and Ds protein levels. Conversely, overexpression of Lft increases levels of Ft and Ds and, reciprocally, overexpression of either Ft or Ds increases levels of Lft, whereas loss of Ft or Ds decreases Lft levels [50] . These effects appear to be post-transcriptional since knockdown of Ft by RNA interference does not influence lft transcript levels and knockdown of Lft does not influence ft transcript levels [50] . Interestingly though, lft transcript levels are reduced when Notch and Wg signalling are disrupted [50] , suggesting that Lft might be a potential integrator of morphogen signalling and SWH signalling. The mechanism by which Lft affects Ft and Ds protein levels is unclear but it might rely on direct protein-protein interactions, as Lft co-precipitates with both Ft and Ds when expressed in S2 cells [50] . Given the strong effect that Lft has on Ft and Ds protein stability, it is surprising that lft mutants are viable with no obvious tissue overgrowth phenotype. Mao and colleagues [50] speculate that this could be due to two reasons: first, even though Ft protein levels are greatly reduced in lft mutants, the small amount of remaining Ft protein might be sufficient for Ft activity; second, loss of lft reduces levels of both Ft and Ds. The partial loss of Ft could be offset by the partial loss of Ds, since Ds appears to regulate Ft depending on the steepness of its expression gradient. A steep gradient of Ds inactivates Ft whereas a shallow gradient activates it [32, 33] . One could imagine that a general reduction of Ds levels would flatten its expression gradient and thus activate Ft signalling.
Relaying Fat Signalling to the Core -Dachs and Approximated How does Ft signal to the core components of the SWH pathway? While no direct physical link has been described between Ft and downstream SWH pathway proteins (Table 1) , genetic epistasis experiments place D between Ft and the core components of the SWH pathway ( Figure 1 [44] . Exactly how D promotes Wts turnover is an important issue that needs to be resolved in order to fully understand the Ft-Wts arm of the pathway. Also pertinent to D function is its localisation: D has a polarised localisation within imaginal disc cells, localizing preferentially to the distal side of cells in a manner modulated by Ft, Ds and Fj [33, 44] . The subcellular localisation of D has been proposed to regulate SWH pathway activity, repressing Ft signalling where D levels are high and permitting Ft signalling where D levels are low [33] . In apparent conflict with this model, D localisation was shown to be unchanged in dco 3 mutant clones [46] , which are known to have impaired Ft signalling [46, 47] . It is possible that this highlights an alternative mode of Ft signalling to the core SWH pathway module that is independent of D localisation.
Another recently discovered regulator of Ft signalling is the DHHC palmitoyltransferase Approximated (App). Like D, App antagonises Ft signalling, as loss of App partially suppresses the tissue overgrowth caused by ft deficiency [52] . App appears to act by regulating the levels and localisation of D; app clones show reduced levels and mislocalisation of D protein, and overexpression of App increases D levels at the subcellular membrane [52] . The effects of App on D localisation appear to be mediated by an as yet unidentified binding partner of D, given that there is no evidence that App directly palmitoylates D [52] .
Fat Signalling and the SWH Pathway in Mammals
Core components of the SWH pathway have been shown to play a growth-regulatory role in both vertebrates and invertebrates, and the mechanism of signalling between these proteins is also largely conserved [4, 5, 20, 21] . To date, however, a definitive link between components of the Ft signalling branch and tissue growth has not been reported in mammals. Mammalian homologues of Ft, Ds, and Fj exist; dchs1 and fjx1 are expressed in opposing gradients, mirroring the expression patterns of their Drosophila homologues Ds and Fj [53, 54] . Loss of ft4, the closest homologue to Drosophila Ft, leads to defects in oriented cell division and planar cell polarity signalling, as well as upregulation of fjx1 [55] . Thus, it appears that the roles of Ft, Ds and Fj in planar cell polarity signalling are conserved in mammals.
Furthermore, Ft4 and Dchs1 interact in a heterophilic fashion in mammalian cultured cells [56] . However, whether they control tissue growth via the SWH pathway in vertebrates requires further investigation. Of note, ft4 and ft1, another ft homologue, are candidate tumour suppressor genes in breast cancer and oral cancer, respectively [57, 58] .
Evidence for a role of downstream Ft signalling components is lacking in vertebrates. Casein kinase 1 d and 3 (CK1d/3) -the mammalian homologues of Drosophila Dco -co-precipitate with FT4 when expressed in HEK293 T cells, but the functional significance of this interaction has not been explored [47] . Lft has two mammalian homologues, Limb expression 1 (Lix1) and Lix1-like (Lix1L) [50] . Both of these can interact with Ft4 when expressed in Drosophila S2 cells, and expression of Lix1L can rescue the wing defect of lft mutants in Drosophila, suggesting that LIX1L can functionally replace Lft [50] . The relevance of D regulation for SWH signalling in vertebrates is presently unclear, as no obvious functional homologue of D has been identified in vertebrates.
The Kibra-Expanded-Merlin Complex Three proteins that are predominantly located at the subapical region of the cell are thought to provide input into the SWH pathway in a largely Fat-independent manner (Figure 1) . These are the two FERM (4.1/ezrin/radixin/moesin) domain-containing proteins Merlin (Mer) and Expanded (Ex) [59] , as well as the recently described WW-domain-containing protein Kibra [60] [61] [62] . Three recent studies identifying Kibra as a key protein acting upstream of the SWH pathway have provided a major advance to our understanding of SWH pathway signalling [60] [61] [62] . As well as defining a new pathway member, these studies have helped to flesh out a conceptual picture of how upstream pathway members control activity of the core kinase module (Figure 1) . Kibra binds to both Mer and Ex, and together these proteins are likely to recruit the core SWH pathway proteins to the apical membrane for activation [60] [61] [62] . Interestingly, multiple interactions were identified between the Kibra-Ex-Mer complex and the core complex ( [14] [15] [16] complex proteins is unclear. One possibility is that they enable multiple upstream inputs that signal via either Kibra, Mer or Ex to be coupled to the core complex, or alternatively they might provide a safeguard against loss of activity of a single Kibra-Ex-Mer complex member. Evidence for such a safeguard is provided by the fact that Kibra, Ex and Mer can at least partially compensate for each other's loss [59] [60] [61] [62] . Presumably this is because interaction between the Kibra-Ex-Mer complex and the core complex is perturbed, but not destroyed, when activity of only one Kibra-Ex-Mer complex protein is lost. The precise mechanism by which proteins of the Kibra-Ex-Mer complex are regulated is unclear; they might respond to a receptor(s) and/or a physical property of the cell (see section on cell tension below). Several studies suggest that the recruitment of the core complex to the apical membrane is important for activation, but the mechanism by which the Kibra-Ex-Mer complex activates the core complex is currently obscure. Given that Wts and Ex both bind Yki, and Kibra binds Wts, one possibility is that Ex recruits Yki to the apical membrane and passes it to Wts to be phosphorylated. Another possibility is that Wts and Yki associate with each other (either in the nucleus or cytoplasm) and are recruited together to a pre-assembled Kibra-Ex-Mer complex that also contains Sav, Hpo and Mats. Once Wts and Yki assemble into the complex, Wts would be stimulated to phosphorylate Yki. The latter scenario, which predicts an accessory role for Ex, rather than a rate-limiting role, is supported by the stronger overgrowth phenotype of tissue lacking wts versus ex, as well as the compensatory relationship observed between Ex, Mer and Kibra. Further support for this model comes from the finding that Kibra affects Wts activity, but not Wts-Yki binding, at least in cultured Drosophila cells [61] .
Kibra, Ex and Mer also appear to have the potential to influence each other's activity: Kibra can promote Mer-Ex binding, whereas Ex potentiates Kibra-Mer binding [61, 62] . This relationship is particularly interesting in view of the fact that deficiency of either kibra, ex or mer affects SWH pathway activity in a temporally restricted and tissuespecific fashion. mer or kibra deficiency leads to greater Yki activation in ovarian follicle cells than ex deficiency, whilst the converse is true in larval imaginal discs [60] [61] [62] . In addition, Ex and Mer appear to control SWH pathway activity in the developing Drosophila eye in a temporally restricted fashion: ex deficiency causes stronger Yki activation in the larval eye than in the pupal eye [63] , and mer, but not ex, is partially required for developmental apoptosis of pupal retinal cells [29, 64] . The activity profile of Ex correlates with its expression profile, which is downregulated as eye development proceeds [63] . One possibility is that different thresholds of Yki activity are required throughout eye development to mediate different biological events and that Ex plays a major role in specification of Yki activity. We hypothesise that, in the larval eye when cells are growing and proliferating, high Ex levels are required to maintain a certain level of SWH pathway activity, whereas in the pupal eye low Ex levels allow a different level of Yki activity that is required to control apoptosis and differentiation of post-mitotic neurons and interommatidial cells. In the pupal eye, lowering the expression levels of Ex would be expected to increase Yki activity in three ways: Ex's ability to activate the core complex would be lowered; Mer-Kibra binding would be weakened, also causing a reduction in activation of the core complex; and inhibition of Yki, mediated by direct interaction with Ex, would be relieved. A greater understanding of the regulation of activity and expression levels of Kibra, Ex and Mer will help to clarify their tissue-and stage-specific roles.
Inhibition of Yorkie by Expanded -Short-Circuiting the Core Complex As well as promoting activity of the core SWH complex, Ex can directly associate with Yki and inhibit its function (Figure 1) , possibly by sequestering Yki at the apical junction [65, 66] . The dual Yki-inhibitory roles of Ex are curious from an evolutionary perspective; what would be the advantage of a protein evolving two independent modes to repress activity of the same protein? The answer to this is not clear, but it is interesting that the likelihood of both of these modes being conserved in mammals is low, given that the closest sequence homologue of Ex -Willin/FRMD6 -lacks the PY motifs that are necessary for the interaction between Ex and the WW domains of Yki [65, 67] .
dRASSF -the Hippo Antagonist
Optimal kinase activation of the core SWH pathway members Hpo and Wts requires both association with their respective co-factors Sav and Mats and assembly into an apically localised protein complex together with Kibra, Ex and Mer (see above). Controlling co-factor association therefore represents another means of controlling Hpo and Wts activity. The Drosophila Ras association family (dRASSF) protein negatively regulates the SWH pathway by competing with Sav for binding to Hpo via a carboxy-terminal Sav/ Rassf/Hippo (SARAH) domain, shared by all three proteins [68, 69] . When bound to dRASSF, Hpo phosphorylation levels are low, indicating that Hpo is inactive [68] . As well as competing for binding to Hpo, dRASSF and Sav negatively regulate each other at the protein level: rassf clones have increased Sav levels and, when Sav is overexpressed, dRASSF levels are lowered [68] . How this reciprocal regulation of protein levels occurs is presently unknown. In addition to its growth-promoting role through inactivation of Hpo, dRASSF also appears to have a growth-inhibitory role that is independent of the SWH pathway, but instead might depend on Ras signalling [68] . The dual roles of dRASSF as either an inhibitor or an activator of tissue growth appear to be conserved among the ten mammalian RASSF homologues. Although the understanding of their cellular functions is limited, RASSF proteins appear to have functions in tissue growth and apoptosis that are either dependent on the Hpo homologues MST1/2, dependent on Ras, or independent of both MST1/2 and Ras [70] [71] [72] .
Apico-Basal Polarity Proteins and the SWH Pathway
It has long been known that loss or gain of function of apicobasal cell polarity regulators -Lgl-Scrib-Dlg, aPKCBazooka-Par6 and Crb-Stardust-PATJ -triggers cell proliferation and/or prevents developmental cell death ( [73, 74] , and reviewed in [75, 76] ), but how this occurs is unknown. Recently, our own study [77] as well as work by Robinson et al. [78] have revealed that the apico-basal cell polarity proteins lethal giant larvae (Lgl), aPKC and Crumbs (Crb) affect cell proliferation and survival by modulating SWH pathway activity. Interestingly, these proteins were shown to influence SWH pathway activity in developing Drosophila epithelial tissues (eye and wing imaginal discs) without grossly altering cell polarity, suggesting that these proteins modulate tissue growth by direct effects on the SWH pathway. In addition, the members of the Lgl-Scrib-Dlg complex were shown to regulate proliferation of Drosophila ovarian follicle cells via Wts; however, in this situation, cell polarity was lost [79] .
aPKC and Lgl regulate SWH pathway activity in an antagonistic fashion; Lgl appears to activate the SWH pathway, and does so by opposing the action of aPKC (Figure 1) . aPKC overexpression or Lgl depletion results in mislocalisation of both Hpo and the Hpo inhibitor dRASSF [68] , but does not affect the levels of several other SWH pathway proteins [77] . Concurrent mislocalisation of dRASSF with Hpo would be expected to prevent Hpo's association with Sav and therefore prevent Hpo activation. A better understanding of how aPKC and Lgl mediate the correct localisation of dRASSF and Hpo will shed light on their role in growth control via the SWH pathway.
The precise role by which Crb influences SWH pathway activity and tissue growth is more complex, because overexpression of crb and crb deficiency can each lead to elevated Yki activity. crb overexpression resulted in excess tissue growth, which was characterised by Crb mislocalisation and reduced expression of Ex [77, 78] . Crb appears to influence SWH pathway activity independent of Lgl and aPKC, as Crb overexpression did not perturb Hpo or dRASSF localisation [77] . Surprisingly, Robinson et al. [78] also found that loss of function of crb increased Yki target gene expression, and resulted in tissue overgrowth. Ex protein abundance was increased in crb mutants, as expected, but it was aberrantly localised basolaterally. Thus, although Ex accumulates in crb mutants, the fact that it is mislocalised suggests that it may be unable to effectively activate the SWH pathway or directly repress Yki. Crb affects Ex levels via its juxtamembrane FERM-domain-binding motif and, at least in cultured cells, Crb influences ubiquitin-mediated turnover of Ex [78] . Deregulation of the vertebrate homologues of the Drosophila apico-basal cell polarity regulators also results in defects in cell proliferation (reviewed by [75] ), although it is not clear whether these proteins regulate tissue growth in vertebrates via the SWH pathway.
Cell Tension and the SWH Pathway
Could the Kibra-Ex-Mer complex be regulated by mechanical forces, such as cell tension? Tissue growth in the wing disc is controlled by a morphogen gradient of Decapentaplegic (Dpp) [80] . However, models that rely on Dpp as the sole instructor of tissue growth cannot be reconciled with some experimental observations (reviewed in [80] ). Tension has therefore been proposed to be a second dynamic feedback mechanism that, in addition to Dpp, could regulate tissue growth [81, 82] . Mathematical modelling has predicted that cell tension increases in a tissue when cells within the tissue proliferate at unequal rates [83] . If tension was to control cell proliferation, it could function as a feedback mechanism that would ensure equal rates of proliferation throughout the tissue. The regulation of cell proliferation by tension is well documented in mammalian cultured cells (reviewed in [84] ). In Drosophila, it has so far not been addressed experimentally, owing to technical limitations, but has been postulated on the basis of computer modelling of tissue growth [81, 82, 85] . Moreover, it has been proposed to control the proliferation of the follicular epithelium that surrounds the growing Drosophila oocyte [86] . The tension exerted on a given cell might be sensed by structural components of cells, such as the actin cytoskeleton. Kibra, Ex and Mer are located at the interface between the plasma membrane and the cortical actin cytoskeleton and would therefore be ideally positioned to sense the tensional state of a cell and could directly translate this information into the regulation of cell proliferation by the SWH pathway. Novel experimental strategies, such as ex vivo culture of imaginal discs to allow experimental modulation of cell tension, are needed in order to address this possibility. Of note, several studies have identified potential regulatory links between the SWH pathway and the actin network and have shown that actin levels are deregulated in Drosophila epithelial cells that have perturbed SWH pathway activity ( [87, 88] , F. Janody and G. Halder, personal communication).
Regulatory Crosstalk Between Upstream Branches of the SWH Pathway
In future studies it will be important to define the relative contribution that each upstream branch of the SWH pathway , Ex levels are repressed and less obvious at the apical junction [29] [30] [31] 45] ; by Crb, which suppresses Ex levels and regulates its localisation [78] ; by Yki activity, which promotes transcription of ex when SWH pathway activity drops [59] , presumably as part of a negative-feedback loop which might normally reinstate Yki repression following a brief pulse of Yki activity; in a temporally restricted fashion in the developing Drosophila eye (Ex levels are lower in the pupal eye than the larval eye) [63] ; and at the level of translation by the microRNA mir-278 [89] .
It should be noted, however, that upstream signalling inputs impact the core kinase cassette in an Ex-independent manner. For example, overgrowth of imaginal disc tissues lacking wts is more severe than of those that lack ex, and wing imaginal discs mutant for both ft and ex overgrow to a greater extent than discs lacking either gene alone [45] . This latter finding suggests that Ft and Ex control Yki activity by responding to different upstream signalling inputs. What then is the significance of Ft-dependent regulation of Ex levels for control of organ size? A likely explanation is that crosstalk occurs between Ft and Ex and Kibra-Ex-Mer complex signalling to ensure appropriate organ size. One might imagine that, in response to reduced Ft-mediated repression of Yki, Ex could at least partially compensate by activating the core SWH pathway complex, as well as by directly sequestering Yki. To overcome such compensation in the face of reduced Ft signalling, a mechanism might have evolved to concomitantly reduce the abundance of Ex -both existing Ex protein as well as newly synthesised Ex generated by the subsequent elevation of Yki activity. It is conceivable that such a mechanism would ensure perdurance of Yki activity for a critical period of time that would allow the required activation of tissue growth (see Figure 3 for further details). To test this hypothesis directly, one would have to disable Ft-mediated regulation of Ex levels and localisation and determine the impact on Yki activity and organ size.
Concluding Remarks
In recent years, our understanding of upstream inputs into the SWH pathway has expanded rapidly. It is likely that further upstream regulators of the SWH pathway await discovery; in mammals, there is evidence that the Wts homologues LATS1/2 can be regulated independently of MST1/2, and that YAP can be phosphorylated by kinases other than LATS1/2 [90] . Furthermore, one would expect a phosphatase(s) to oppose the phosphorylation of different SWH pathway proteins. Such proteins might be difficult to discover using traditional genetic screening techniques that rely on alterations in tissue growth for two reasons: first, loss of a single upstream SWH pathway regulatory branch has only a mild effect on tissue growth (Figure 2) , presumably due to compensatory regulation and feedback loops as described above; second, novel upstream regulators might have pleiotropic functions, such as Ft and Ds in planar cell polarity, aPKC-Lgl and Crb in apico-basal polarity, or dRASSF in Ras signalling, which could mask their roles in SWH signalling. Unconventional screening approaches are therefore likely to be required to uncover further upstream regulatory proteins of the SWH pathway.
A facet of growth control mediated by the SWH pathway that is poorly understood is how its signalling output is integrated with other growth-controlling pathways to co-ordinately define tissue size. Several points of potential crosstalk have been identified between such pathways and the SWH pathway: the morphogens, Wg and Dpp, control the expression of Ds and Fj [26, 33] , whilst the expression of Wg and the Notch pathway ligand Ser can be augmented by Yki [44] . Yki can also modulate morphogen signalling by controlling the expression of the heparan sulfate proteoglycans Dally and Dally-like [91] . Furthermore, the expression of Lft, which controls levels of the Ft and Ds proteins, is controlled by the Notch and Wg pathways [50] , whilst insulin, target of rapamycin, Wg and Notch pathways, in addition to the SWH pathway, have all been shown to converge on the growth regulatory microRNA bantam [92] [93] [94] .
Since its discovery less than 10 years ago, our understanding of SWH pathway signalling has grown at an astonishing rate and has allowed the various layers of complexity inherent in this pathway to begin to be unravelled. Future studies are sure to identify further intricacies of SWH pathway signalling which will increase our understanding of how this pathway impacts tissue growth during normal development, as well as in human pathologies, such as cancer.
